Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
| FRBSX Fund | USD 40.08 0.10 0.25% |
Slightly above 62% of Franklin Balance's investor base is looking to short. The analysis of overall sentiment of trading Franklin Balance Sheet mutual fund suggests that many investors are alarmed at this time. Franklin Balance's investing sentiment can be driven by a variety of factors including economic data, Franklin Balance's earnings reports, geopolitical events, and overall market trends.
Franklin |
Novartis has entered into an exclusive license and collaboration agreement with Ratio Therapeutics for the development of a SSTR2 radiotherapeutic candidate for cancer.
Read at seekingalpha.com
 |
Franklin Balance Fundamental Analysis
We analyze Franklin Balance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Franklin Balance using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Franklin Balance based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Franklin Balance is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Franklin Balance Sheet Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Franklin Balance mutual fund to make a market-neutral strategy. Peer analysis of Franklin Balance could also be used in its relative valuation, which is a method of valuing Franklin Balance by comparing valuation metrics with similar companies.
Peers
Franklin Balance Related Equities
| MSTSX | Morningstar Unconstrained | 1.28 | ||||
| AAEVX | American Century | 0.52 | ||||
| ABHYX | High-yield Municipal | 0.33 | ||||
| VMVAX | Vanguard Mid-cap | 0.05 | ||||
| BRRAY | Barloworld | 0.00 | ||||
| LBHIX | Thrivent High | 0.23 | ||||
| VIASP | Via Renewables | 0.32 | ||||
| 444859BR2 | HUMANA | 1.70 |
Other Information on Investing in Franklin Mutual Fund
Franklin Balance financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Balance security.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets |